Literature DB >> 21645619

IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence.

Demet Akin1, Teresa Ravizza, Mattia Maroso, Nihan Carcak, Tugba Eryigit, Ilaria Vanzulli, Rezzan Gülhan Aker, Annamaria Vezzani, Filiz Yılmaz Onat.   

Abstract

Interleukin (IL)-1β plays a crucial role in the mechanisms of limbic seizures in rodent models of temporal lobe epilepsy. We addressed whether activation of the IL-1β signaling occurs in rats with genetic absence epilepsy (GAERS) during the development of spike-and-wave discharges (SWDs). Moreover, we studied whether inhibition of IL-1β biosynthesis in GAERS could affect SWD activity. IL-1β expression and glia activation were studied by immunocytochemistry in the forebrain of GAERS at postnatal days (PN)14, PN20, and PN90 and in age-matched non-epileptic control Wistar rats. In PN14 GAERS, when no SWDs have developed yet, IL-1β immunostaining was undetectable, and astrocytes and microglia showed a resting phenotype similar to control Wistar rats. In 3 out of 9 PN20 GAERS, IL-1β was observed in activated astrocytes of the somatosensory cortex; the cytokine expression was associated with the occurrence of immature-type of SWDs. In all adult PN90 GAERS, when mature SWDs are established, IL-1β was observed in reactive astrocytes of the somatosensory cortex but not in adjacent cortical areas or in extra-cortical regions. An age-dependent c-fos activation was found in the somatosensory cortex of GAERS with maximal levels reached in PN90 rats; c-fos was also induced in some thalamic nuclei in PN20 and PN90 GAERS. Inhibition of IL-1β biosynthesis in PN90 GAERS by 4-day systemic administration of a specific ICE/Caspase-1 blocker, significantly reduced both SWD number and duration. These results show that IL-1β is induced in reactive astrocytes of the somatosensory cortex of GAERS at the onset of SWDs. IL-1β has pro-ictogenic properties in this model, and thus it may play a contributing role in the mechanisms underlying the occurrence of absence seizures.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645619     DOI: 10.1016/j.nbd.2011.05.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 2.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

3.  Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.

Authors:  Dai-Shi Tian; Jiyun Peng; Madhuvika Murugan; Li-Jie Feng; Jun-Li Liu; Ukpong B Eyo; Li-Jun Zhou; Rochelle Mogilevsky; Wei Wang; Long-Jun Wu
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

4.  Disease-Modifying Effects of Neural Regeneration Peptide 2945 in the GAERS Model of Absence Epilepsy.

Authors:  Gabi Dezsi; Frank Sieg; Mark Thomas; Terence J O'Brien; Marieke van der Hart; Nigel C Jones
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

5.  Astrocytes and absence epilepsy.

Authors:  Filiz Onat
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 6.  Immunity and Inflammation in Epilepsy.

Authors:  Annamaria Vezzani; Bethan Lang; Eleonora Aronica
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

7.  Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.

Authors:  Antonio Leo; Rita Citraro; Nicola Amodio; Caterina De Sarro; Maria Eugenia Gallo Cantafio; Andrew Constanti; Giovambattista De Sarro; Emilio Russo
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Therapy with the Combination of Amlodipine and Irbesartan Has Persistent Preventative Effects on Stroke Onset Associated with BDNF Preservation on Cerebral Vessels in Hypertensive Rats.

Authors:  Yu Hasegawa; Takashi Nakagawa; Ken Uekawa; Mingjie Ma; Bowen Lin; Hiroaki Kusaka; Tetsuji Katayama; Daisuke Sueta; Kensuke Toyama; Nobutaka Koibuchi; Shokei Kim-Mitsuyama
Journal:  Transl Stroke Res       Date:  2014-12-23       Impact factor: 6.829

9.  Suppressive effect of Rho-kinase inhibitors Y-27632 and fasudil on spike-and-wave discharges in genetic absence epilepsy rats from Strasbourg (GAERS).

Authors:  Nihan Çarçak; Melis Yavuz; Tuğba Eryiğit Karamahmutoğlu; Akif Hakan Kurt; Meral Urhan Küçük; Filiz Yılmaz Onat; Kansu Büyükafsar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-02       Impact factor: 3.000

Review 10.  Does brain inflammation mediate pathological outcomes in epilepsy?

Authors:  Karen S Wilcox; Annamaria Vezzani
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.